AAA
IBIO icon

Affinity Asset Advisors’s iBio IBIO Stock Holding History

Affinity Asset Advisors’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.01M Buy
4,007,881
+900,681
+29% +$1.61M 0.32% 68
2026
Q1 		$5.9M Buy
3,107,200
+1,050,000
+51% +$2.44M 0.3% 64
2025
Q4 		$3.97M Buy
+2,057,200
New +$2.81M 0.23% 69

Other funds holding IBIO

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Affinity Asset Advisors's IBIO Position: Q2 2026 in Review

Affinity Asset Advisors increased its iBio (IBIO) stake by 29% in Q2 2026, buying an estimated $1.61M and bringing the position to 4,007,881 shares worth $7.01M. The position accounts for 0.32% of the portfolio, ranked #68.

Affinity Asset Advisors first reported a position in IBIO in Q4 2025 and has held it in 3 quarters since. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Affinity Asset Advisors held 4,007,881 shares of iBio worth $7.01M as of Q2 2026.
  • Affinity Asset Advisors bought 900,681 iBio shares in Q2 2026, an estimated $1.61M.
  • iBio made up 0.32% of Affinity Asset Advisors's portfolio in Q2 2026, its #68 holding.
  • Affinity Asset Advisors first reported a position in iBio in Q4 2025 and has held it in 3 quarters since.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Affinity Asset Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.